Cyclin dependent kinases (CDKs), such as Cyclin D/E and CDK2/4/6, which are involved in promoting cell cycle progression, are often overexpressed, while cyclin-dependent kinases (CDKIs), such as p21 and p27, are generally downregulated in cancer cells (27). Here, CDK2 is linked to cancer.